Healthcare -
Biotechnology - NASDAQ - US
$ 1.33
-6.34 %
$ 41.7 M
Market Cap
-0.56
P/E
ACRV - REVENUE
Revenue ACRV - Acrivon Therapeutics, Inc. Common Stock
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR